(July 9, 2024, 1:13 PM EDT) -- BOSTON — A recent study published in the JAMA Ophthalmology found a potential link between semaglutide, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), and an increased risk of a significant cause of blindness among adults....